Diluted EPS came in at $-0.17, beat the $-0.20 consensus by $0.03.
Trailing eight quarters through Q4 2024
Common questions about MAIA Biotechnology's Q4 2024 earnings report.
MAIA Biotechnology (MAIA) reported Q4 2024 earnings on March 21, 2025 before market open.
MAIA Biotechnology reported diluted EPS of $-0.17 for Q4 2024.
EPS beat the consensus estimate of $-0.20 by $0.03.
You can read the 10-K periodic report (0000950170-25-043190) directly on SEC EDGAR. The filing index links above go to sec.gov.